168 related articles for article (PubMed ID: 27469284)
1. A closer look at strategies for preserving salivary gland function after radiotherapy in the head and neck region.
Galvão-Moreira LV; Santana T; da Cruz MC
Oral Oncol; 2016 Sep; 60():137-41. PubMed ID: 27469284
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy-induced salivary dysfunction.
Ship JA; Hu K
Semin Oncol; 2004 Dec; 31(6 Suppl 18):29-36. PubMed ID: 15726520
[TBL] [Abstract][Full Text] [Related]
3. Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients.
Jensen SB; Vissink A; Limesand KH; Reyland ME
J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425600
[TBL] [Abstract][Full Text] [Related]
4. Assessment of post-radiotherapy salivary glands.
Cheng SC; Wu VW; Kwong DL; Ying MT
Br J Radiol; 2011 May; 84(1001):393-402. PubMed ID: 21511748
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology and management of radiation-induced xerostomia.
Berk LB; Shivnani AT; Small W
J Support Oncol; 2005; 3(3):191-200. PubMed ID: 15915820
[TBL] [Abstract][Full Text] [Related]
6. Salivary gland sparing in the treatment of head and neck cancer.
Scrimger R
Expert Rev Anticancer Ther; 2011 Sep; 11(9):1437-48. PubMed ID: 21929317
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging for evaluation of salivary gland function in head and neck cancer patients treated with intensity-modulated radiotherapy.
Loimu V; Seppälä T; Kapanen M; Tuomikoski L; Nurmi H; Mäkitie A; Tenhunen M; Saarilahti K
Radiother Oncol; 2017 Feb; 122(2):178-184. PubMed ID: 27475276
[TBL] [Abstract][Full Text] [Related]
8. TAT-mediated delivery of Tousled protein to salivary glands protects against radiation-induced hypofunction.
Sunavala-Dossabhoy G; Palaniyandi S; Richardson C; De Benedetti A; Schrott L; Caldito G
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):257-65. PubMed ID: 22285666
[TBL] [Abstract][Full Text] [Related]
9. Scintigraphy in prediction of the salivary gland function after gland-sparing intensity modulated radiation therapy for head and neck cancer.
Tenhunen M; Collan J; Kouri M; Kangasmäki A; Heikkonen J; Kairemo K; Mäkitie A; Joensuu H; Saarilahti K
Radiother Oncol; 2008 May; 87(2):260-7. PubMed ID: 18329118
[TBL] [Abstract][Full Text] [Related]
10. Double blind randomized prospective trial of bethanechol in the prevention of radiation-induced salivary gland dysfunction in head and neck cancer patients.
Jaguar GC; Lima EN; Kowalski LP; Pellizzon AC; Carvalho AL; Boccaletti KW; Alves FA
Radiother Oncol; 2015 May; 115(2):253-6. PubMed ID: 25890572
[TBL] [Abstract][Full Text] [Related]
11. Toxicity and compliance of subcutaneous amifostine in patients undergoing postoperative intensity-modulated radiation therapy for head and neck cancer.
Thorstad WL; Chao KS; Haughey B
Semin Oncol; 2004 Dec; 31(6 Suppl 18):8-12. PubMed ID: 15726516
[TBL] [Abstract][Full Text] [Related]
12. Current ideas to reduce or salvage radiation damage to salivary glands.
Vissink A; van Luijk P; Langendijk JA; Coppes RP
Oral Dis; 2015 Jan; 21(1):e1-10. PubMed ID: 24581290
[TBL] [Abstract][Full Text] [Related]
13. Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.
van Luijk P; Pringle S; Deasy JO; Moiseenko VV; Faber H; Hovan A; Baanstra M; van der Laan HP; Kierkels RG; van der Schaaf A; Witjes MJ; Schippers JM; Brandenburg S; Langendijk JA; Wu J; Coppes RP
Sci Transl Med; 2015 Sep; 7(305):305ra147. PubMed ID: 26378247
[TBL] [Abstract][Full Text] [Related]
14. Impact of submandibular gland excision on salivary gland function in head and neck cancer patients.
Jaguar GC; Lima EN; Kowalski LP; Pellizon AC; Carvalho AL; Alves FA
Oral Oncol; 2010 May; 46(5):349-54. PubMed ID: 20227906
[TBL] [Abstract][Full Text] [Related]
15. On approaches to the functional restoration of salivary glands damaged by radiation therapy for head and neck cancer, with a review of related aspects of salivary gland morphology and development.
Redman RS
Biotech Histochem; 2008 Jun; 83(3-4):103-30. PubMed ID: 18828044
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of irradiated salivary gland function in patients with head and neck tumours treated with radiotherapy.
Baharudin A; Khairuddin A; Nizam A; Samsuddin AR
J Laryngol Otol; 2009 Jan; 123(1):108-13. PubMed ID: 18452635
[TBL] [Abstract][Full Text] [Related]
17. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.
Chambers MS; Garden AS; Kies MS; Martin JW
Head Neck; 2004 Sep; 26(9):796-807. PubMed ID: 15350026
[TBL] [Abstract][Full Text] [Related]
18. Acquired salivary dysfunction. Drugs and radiation.
Fox PC
Ann N Y Acad Sci; 1998 Apr; 842():132-7. PubMed ID: 9599303
[TBL] [Abstract][Full Text] [Related]
19. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine.
Münter MW; Hoffner S; Hof H; Herfarth KK; Haberkorn U; Rudat V; Huber P; Debus J; Karger CP
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):651-9. PubMed ID: 17175118
[TBL] [Abstract][Full Text] [Related]
20. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer].
Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J
Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
